Melanoma-associated genes, MXI1, FN1, and NME1, are hypoxia responsive in murine and human melanoma cells.

作者: Magdalena Olbryt , Anna Habryka , Tomasz Tyszkiewicz , Aleksandra Rusin , Tomasz Cichoń

DOI: 10.1097/CMR.0B013E328348DB2F

关键词: Transcription factorMicrophthalmia-associated transcription factorSTAT proteinSTAT3Galectin-3Gene expressionCell cultureMolecular biologyMelanomaCancer researchBiology

摘要: Hypoxia can influence aggressiveness of melanoma by inducing specific gene expression profiles. In our previous microarray study, we identified more than 430 hypoxia-responsive genes in the B16-F10 murine cell line vitro. Of identified, seven genes: galectin 3 (Lgals3), adhesion molecule (Mcam), fibronectin 1 (Fn1), signal transducer and activator transcription (Stat3), microphthalmia-associated factor (Mitf), max interacting protein (Max1), non-metastatic cells 1, (NM23A) expressed (Nme1) are known to be associated with melanoma, but have not yet been reported as being regulated hypoxia human cells. this investigated whether these is modulated microdissected areas experimental tumors vivo, well commercially available lines (WM35, WM1552C, WM793B, WM278, 1205Lu, 451Lu) exposed hypoxic conditions Our analysis revealed significant agreement between in-vitro in-vivo results showing that all except Mitf were oxygen-deprived tumor regions (P<0.05). contrast, three (NME1, MXI1 FN1) proved both mouse link genes, for first time, microenvironment imply widely used model could a convenient research tool further investigation their role development course malignancy.

参考文章(46)
Adrian L. Harris, Hypoxia — a key regulatory factor in tumour growth Nature Reviews Cancer. ,vol. 2, pp. 38- 47 ,(2002) , 10.1038/NRC704
Okot Nyormoi, Menashe Bar-Eli, Transcriptional regulation of metastasis-related genes in human melanoma Clinical & Experimental Metastasis. ,vol. 20, pp. 251- 263 ,(2003) , 10.1023/A:1022991302172
M. Bittner, P. Meltzer, Y. Chen, Y. Jiang, E. Seftor, M. Hendrix, M. Radmacher, R. Simon, Z. Yakhini, A. Ben-Dor, N. Sampas, E. Dougherty, E. Wang, F. Marincola, C. Gooden, J. Lueders, A. Glatfelter, P. Pollock, J. Carpten, E. Gillanders, D. Leja, K. Dietrich, C. Beaudry, M. Berens, D. Alberts, V. Sondak, N. Hayward, J. Trent, Molecular classification of cutaneous malignant melanoma by gene expression profiling Nature. ,vol. 406, pp. 536- 540 ,(2000) , 10.1038/35020115
CHRISTINE E. HORAK, JONG HEUN LEE, JEAN-CLAUDE MARSHALL, S. MARTIN SHREEVE, PATRICIA S. STEEG, The role of metastasis suppressor genes in metastatic dormancy. Apmis. ,vol. 116, pp. 586- 601 ,(2008) , 10.1111/J.1600-0463.2008.01027.X
Allal Ouhtit, Rajiv L. Gaur, Zakaria Y. Abd Elmageed, Augusta Fernando, Rajesh Thouta, Alison K. Trappey, Mohamed E. Abdraboh, Hassan I. El-Sayyad, Prakash Rao, Madhwa G.H. Raj, Towards understanding the mode of action of the multifaceted cell adhesion receptor CD146 Biochimica et Biophysica Acta. ,vol. 1795, pp. 130- 136 ,(2009) , 10.1016/J.BBCAN.2009.01.002
S. M. Ariyanayagam-Baksh, Loss of Heterozygosity in the MXI1 Gene Is a Frequent Occurrence in Melanoma Modern Pathology. ,vol. 16, pp. 992- 995 ,(2003) , 10.1097/01.MP.0000087421.44975.1C
Khaled Ezzedine, Ghanem Ghanem, Michel Heenen, Pierre Vereecken, Ahmad Awada, Stefan Suciu, Gilberto Castro, Renato Morandini, Anna Litynska, Danielle Lienard, Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients. Melanoma Research. ,vol. 19, pp. 316- 320 ,(2009) , 10.1097/CMR.0B013E32832EC001
Manuela Kaspar, Luciano Zardi, Dario Neri, Fibronectin as target for tumor therapy. International Journal of Cancer. ,vol. 118, pp. 1331- 1339 ,(2006) , 10.1002/IJC.21677
Aaron R. Jeffs, Amy C. Glover, Lynn J. Slobbe, Li Wang, Shujie He, Jody A. Hazlett, Anshul Awasthi, Adele G. Woolley, Elaine S. Marshall, Wayne R. Joseph, Cristin G. Print, Bruce C. Baguley, Michael R. Eccles, A gene expression signature of invasive potential in metastatic melanoma cells. PLOS ONE. ,vol. 4, ,(2009) , 10.1371/JOURNAL.PONE.0008461